Sweden
· Delayed Price · Currency is SEK Redsense Medical AB Statistics
Total Valuation
Redsense Medical AB has a market cap or net worth of SEK 121.69 million. The enterprise value is 105.62 million.
| Market Cap | 121.69M |
| Enterprise Value | 105.62M |
Important Dates
The next estimated earnings date is Friday, February 21, 2025.
| Earnings Date | Feb 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Redsense Medical AB has 16.44 million shares outstanding. The number of shares has increased by 15.55% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 16.44M |
| Shares Change (YoY) | +15.55% |
| Shares Change (QoQ) | +5.25% |
| Owned by Insiders (%) | 3.40% |
| Owned by Institutions (%) | 27.07% |
| Float | 10.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.02 |
| PB Ratio | 3.47 |
| P/TBV Ratio | 3.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -16.93 |
| EV / Sales | 4.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.08 |
Financial Position
The company has a current ratio of 5.35
| Current Ratio | 5.35 |
| Quick Ratio | 4.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.77 |
Financial Efficiency
Return on equity (ROE) is -21.20% and return on invested capital (ROIC) is -13.26%.
| Return on Equity (ROE) | -21.20% |
| Return on Assets (ROA) | -11.36% |
| Return on Capital (ROIC) | -13.26% |
| Revenue Per Employee | 4.84M |
| Profits Per Employee | -1.25M |
| Employee Count | 5 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 2.55 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.50% in the last 52 weeks. The beta is 0.49, so Redsense Medical AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -10.50% |
| 50-Day Moving Average | 6.93 |
| 200-Day Moving Average | 6.87 |
| Relative Strength Index (RSI) | 59.57 |
| Average Volume (20 Days) | 4,841 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Redsense Medical AB had revenue of SEK 24.22 million and -6.24 million in losses. Loss per share was -0.38.
| Revenue | 24.22M |
| Gross Profit | 14.32M |
| Operating Income | -6.25M |
| Pretax Income | -6.24M |
| Net Income | -6.24M |
| EBITDA | -6.18M |
| EBIT | -6.25M |
| Loss Per Share | -0.38 |
Balance Sheet
| Cash & Cash Equivalents | 16.07M |
| Total Debt | n/a |
| Net Cash | 16.07M |
| Net Cash Per Share | 0.98 |
| Equity (Book Value) | 35.02M |
| Book Value Per Share | 2.13 |
| Working Capital | 21.20M |
Cash Flow
In the last 12 months, operating cash flow was -9.52 million and capital expenditures -17,000, giving a free cash flow of -9.54 million.
| Operating Cash Flow | -9.52M |
| Capital Expenditures | -17,000 |
| Free Cash Flow | -9.54M |
| FCF Per Share | -0.58 |
Margins
Gross margin is 59.14%, with operating and profit margins of -25.79% and -25.76%.
| Gross Margin | 59.14% |
| Operating Margin | -25.79% |
| Pretax Margin | -25.76% |
| Profit Margin | -25.76% |
| EBITDA Margin | -25.52% |
| EBIT Margin | -25.79% |
| FCF Margin | n/a |
Dividends & Yields
Redsense Medical AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.55% |
| Shareholder Yield | -15.55% |
| Earnings Yield | -5.13% |
| FCF Yield | -7.84% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Redsense Medical AB has an Altman Z-Score of 14.71.
| Altman Z-Score | 14.71 |
| Piotroski F-Score | n/a |